Official Guidance (2026)
Mgmt Quotes
| Metric | Value | Speaker/Context |
|---|---|---|
| Q4 2025 Revenue | $25.2M | CFO (record, +18% QoQ, +137% YoY) |
| FY 2025 Revenue | $73.0M | CEO (3x vs. 2024) |
| Q4 2025 Gross Margin | 24% | CEO (+9ppt QoQ, +45ppt YoY) |
| FY 2025 Gross Margin | 11% | CEO (vs. -76% in 2024) |
| Q4 2025 GAAP Net Loss | ($24.3M), -$0.18/sh | CFO (132.1M shares) |
| Q4 2025 Adjusted EBITDA | ($1.8M) | CFO |
| FY 2025 Adjusted EBITDA (ex-CO) | ($5.3M) | CFO (excluding Colorado costs) |
| Year-end Cash | $90.5M | CFO (no debt) |
| FY 2026 Revenue Guidance | ≥$125M | CFO |
| FY 2026 Adj. EBITDA Guidance | ≥$4M | CFO |
| DIU Contract Value | $14.8M | CEO |
| Cell Designs in Portfolio | 22 | CEO |